Thursday, July 20, 2017 12:38:02 PM
ADAD is moving forward again, big profits are around the corner
Hello members,
After a pretty ugly start of the week, shares of ADAD moved up yesterday.
This does not surprise me as I had accurately predicted the move up in my email to you 24 hours ago.
ADAD is following the chart pattern of the last 2 dips which occurred in June which means that we can expect to see it back to around 60 cents some time next week.
I remain confident that after this recovery, ADAD will get a tail wind which will push it up to $1 per share in no time.
This is why it’s so important that you keep holding your shares, if you’re currently a shareholder…
and if you’re not then you need to do yourself a favor and buy in early today to ride the profits all the way up.
Both Samsung and Verizon have put their trust in ADAD, shouldn’t we as well?
They are some of the biggest companies on the planet and they’re working on revolutionary technologies with ADAD .
To me, this proves that ADAD is a company that should be taken very seriously in the 3D printing industry.
All my analyst friends agree that the recent lackluster performance of the stock is simply due to intense short selling, and that in the next few days ADAD will recover.
I recommend that you continue being patient if you own shares of ADAD and use this opportunity to tell your friends to buy because the stock is trading at a big discount to last week.
adad stock price recovering nicely
Sincerely Yours
Scott Dealy
Chief Analyst for ThePennyStockNewsletter.com
ADAD hit .085 on Wednesday 7/19
Recent ADAD News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/01/2023 06:10:37 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/17/2023 04:01:54 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM